Pedro Emanuel Rubini Liedke

Challenges to effective cancer control in China, India, and Russia

Paul E. Goss, Kathrin Strasser‐Weippl, Brittany Bychkovsky et al. · The Lancet Oncology · 2014 · 504 citations

Public Health, Health Policy, Oncology +12

Durvalumab Plus Carboplatin/Paclitaxel Followed by Maintenance Durvalumab With or Without Olaparib as First-Line Treatment for Advanced Endometrial Cancer: The Phase III DUO-E Trial

Shannon N. Westin, Kathleen N. Moore, Hye Sook Chon et al. · Journal of Clinical Oncology · 2023 · 331 citations · Full text

Medicine, Oncology, Pharmacology +12

Exemestane Versus Anastrozole in Postmenopausal Women With Early Breast Cancer: NCIC CTG MA.27—A Randomized Controlled Phase III Trial

Paul E. Goss, James N. Ingle, Kathleen I. Pritchard et al. · Journal of Clinical Oncology · 2013 · 260 citations

Medicine, Oncology, Pharmacology +17

Datopotamab Deruxtecan Versus Chemotherapy in Previously Treated Inoperable/Metastatic Hormone Receptor–Positive Human Epidermal Growth Factor Receptor 2–Negative Breast Cancer: Primary Results From TROPION-Breast01

Aditya Bardia, Komal Jhaveri, Seock‐Ah Im et al. · Journal of Clinical Oncology · 2024 · 140 citations · Full text

Medicine, Oncology, Pharmacology +17

Outcomes of Breast Cancer in Brazil Related to Health Care Coverage: A Retrospective Cohort Study

Pedro Emanuel Rubini Liedke, Dianne M. Finkelstein, Jackie Szymonifka et al. · Cancer Epidemiology Biomarkers & Prevention · 2013 · 111 citations · Full text

Medicine, Health Policy, Oncology +16